Análogos de somatostatina: para que servem octreotida e lanreotida

Somatostatin analogs, such as octreotide (Sandostatin®) and lanreotide (Somatuline®), are among the most important treatments for neuroendocrine tumors. In this video, you will understand clearly and based on evidence how these medications work, when they are indicated, and what side effects may occur during treatment. If you have recently been diagnosed with a neuroendocrine tumor or are researching octreotide, lanreotide, and carcinoid syndrome, this content was prepared to help clarify the main questions of patients and their families. 🔍 What you will find in this guide: What are somatostatin analogs? Understand the role of somatostatin in the body and why long-acting synthetic versions, such as octreotide and lanreotide, were developed. How Octreotide and Lanreotide Work in Neuroendocrine Tumors See how these medications bind to receptors present in tumor cells and help control symptoms and disease progression. Octreotide: What is it for? Learn about the main indications for octreotide in the control of carcinoid syndrome, functional tumors, and in the treatment of well-differentiated neuroendocrine tumors. Lanreotide and Side Effects Find out about the most common adverse effects, including discomfort at the injection site, bowel changes, gallstones, and changes in glucose levels. Control of Hormonal Symptoms Understand how somatostatin analogs help reduce diarrhea, flushing, and other symptoms related to excessive hormone production. Control of Tumor Growth Learn about the scientific evidence demonstrating the role of these medications in stabilizing the disease in selected patients. Monthly Application and Follow-up See how long-acting injections work, the frequency of applications, and the necessary care during treatment. Imaging and Nuclear Medicine Exams Discover how somatostatin receptors are also used in advanced exams, such as PET-CT with Gallium-68, and in treatments like Lutetium-177 DOTATATE. Quality medical information is an important tool for patients and families to better understand each stage of treatment. Individualized follow-up with a specialist is fundamental to defining the best care strategies according to the characteristics of each case. 👍 Did this content help bring relief and clarify your treatment options? Leave a like and share with patients and families who also need reliable and up-to-date information. 🔔 Subscribe to the channel to follow more content about neuroendocrine tumors, clinical oncology, carcinoid syndrome, octreotide, lanreotide, and cancer treatments with Dr. Hugo Tanaka. Dr. Hugo Tanaka Clinical Oncologist CRM 163241 | RQE 100689 – Clinical Oncology Website: https://drhugotanaka.com.br/